Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071149A2 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000WO2000071147A1 Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
11/30/2000WO2000071146A2 Glutathione reductase for therapy and prophylaxis of aids
11/30/2000WO2000071144A1 Prolyl endopeptidase inhibitor
11/30/2000WO2000071141A1 Modified factor viii
11/30/2000WO2000071135A1 Anti-tumor comprising boroproline compounds
11/30/2000WO2000071126A1 Quinoxaline containing medicaments for post exposure prophylaxis of an hiv infection
11/30/2000WO2000071096A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
11/30/2000WO2000071081A2 Methods of diagnosis and treatment of meniere disease
11/30/2000WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000WO2000070945A2 Fatty acid elongation genes and uses thereof
11/30/2000WO2000050620A3 Human endokine alpha and methods of use
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000049892A3 Dietetic supplement from human placenta
11/30/2000WO2000047735A3 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
11/30/2000WO2000047615A3 Proteins related to neuronal regeneration and uses thereof
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000047610A3 Method for altering undesirable immune responses to polypeptides
11/30/2000WO2000045832A3 Regulation of anaesthesia
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000043037A3 Hiv-encoded chemoattractant
11/30/2000WO2000043028A3 Method of treating chronic cardiac disease
11/30/2000WO2000042993A3 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042188A3 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
11/30/2000WO2000042178A3 Antagonist blockade of crf2 receptors for the treatment of psy chiatric disorders and the use of chimeric antisense oligonucleotides in in vivo cns studies of gene function
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000041537A3 Use of desert hedgehog protein
11/30/2000WO2000040606A3 Modulation of hiv replication using sam68
11/30/2000WO2000040605A3 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
11/30/2000WO2000040269A3 Pharmaceutical compositions for treatment of diseased tissues
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000037096A3 Treatment of hepatitis c virus infections with interleukin-10
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000033814A3 Method for administering agents to the central nervous system
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000031254A3 Apoptosis-inducing factor
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000027340A9 USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000024415A9 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000021572A3 Hydrogels and water soluble polymeric carriers for drug delivery
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375072A1 Prodrug activation using catalytic antibodies
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374532A1 Recombinant bacterial phytases and uses thereof
11/30/2000CA2374531A1 Diagnostics and therapeutics for restenosis
11/30/2000CA2374499A1 Antisense to c-myc for treatment of polycystic kidney disease
11/30/2000CA2374421A1 High specificity hairpin antisense oligonucleotides
11/30/2000CA2374416A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374341A1 Novel polypeptide
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2374273A1 Liver function controlling agents
11/30/2000CA2374050A1 Vascular endothelial growth factor dimers
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373643A1 Anti-tumor comprising boroproline compounds
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2373262A1 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/30/2000CA2366408A1 Inhibition of histone deacetylase
11/29/2000EP1055720A2 Compositions for stabilizing oxygen-labile species
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1055684A1 Tumor antigen peptide derivatives
11/29/2000EP1055683A1 Novel acetamide derivative and use thereof
11/29/2000EP1055429A1 Novel preventives/remedies for immunopathy
11/29/2000EP1054998A1 Transglutaminase linkage of agents to tissue
11/29/2000EP1054997A1 Method for developing a pharmaceutical active ingredient
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054988A1 Anti-viral vectors
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000EP1054983A1 Antagonists of g-protein-coupled receptor
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054979A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054966A1 Ammaid, a g protein coupled receptor
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
1 ... 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 ... 3163